Thank you for donating!

You can donate using the following services.

Supporting those affected by Niemann-Pick diseases

NPUK 24th Annual Family Conference & Interactive Workshop

Our 24th Annual Family Conference will be held from the 22nd to the 24th of September 2017, in the beautiful Mecure Haydock Hotel - book your place now!

Explore NPUK

View all

Latest news


CTD Holdings to Host Webinar to Provide Update on Trappsol® Cyclo™ Drug Development Program for Treatment of Niemann-Pick Disease Type C

CTD Holdings, Inc. (OTCQB: CTDH), a clinical stage biotechnology company that develops cyclodextrin-based products for the treatment of disease, today announced that it will host a webinar to provide details of the Company’s recently initiated Phase I clinical trial in the U.S. and Phase I/II clinical trial in the EU, both evaluating CTD’s proprietary formulation of hydroxypropyl beta cyclodextrin, Trappsol® Cyclo™, for the treatment of Niemann-Pick Disease Type C (NPC). NPC is a rare and fatal genetic disease that damages the brain, lung, liver, spleen, and other organs.

Read more


NPUK Annual Family Conference & Interactive Workshop 2017

We are looking forward to our next Annual Family Conference & Interactive Workshop, and we hope you are too! The event is the biggest in the NPUK calendar, and this year will be held 22nd-24th September 2017 at the Mercure Haydock Hotel, Merseyside, UK.

Read more
View all news Subscribe